MGTX (MeiraGTx Holdings) Gross Return on Sales

Official company branding of MeiraGTx PLC (MGTX)

MeiraGTx Holdings plc (MGTX) relies on unique gene delivery patents, which guarantee a stable income stream. High barriers to entry and strict regulatory oversight protect the niche from new players. On GURU.Markets, the gross profit margin trend shows that the indicator level is 94.30. Meanwhile, laboratory maintenance creates significant costs, keeping the economics at a pre-clinical stage until drug approval.

MGTX MeiraGTx Holdings Gross Profitability (07/04/2022 - 11/20/2026)

Analytical breakdowns and data insights for company meiragtx.com (MGTX)

- share price and consensus valuation forecast:
- business market valuation indicators:
- cash balance and cash flow data:
Summary company analysis:MeiraGTx Holdings (MGTX)
Original product of MeiraGTx Holdings plc

Gross margin determines the portion of revenue remaining after covering direct production costs, allowing for an assessment of cost management efficiency and the asset's pricing power. By analyzing the gross margin ratio, an investor can see the impact of the hybrid model of MeiraGTx Holdings plc (MGTX), which combines internal DNA drug production capacities with the delegation of late-stage trials to external CROs to optimize operating expenses and minimize risks.

Main competitors

Return on Gross Profit Tempus AI Inc|QGEN (Qiagen NV) - Gross Margin|Return on Gross Profit Ionis Pharma (IONS)|Gross Profitability Repligen Corp (RGEN)|RNA - Gross Profit Margin|crisprtx.com - Return on Gross Profit|Gross Profit Rate WGS|RARE - Gross Profitability|Beam Tx (BEAM) - Return on Gross Profit|SRPT (Sarepta Therapeutics Inc) - Return on Gross Profit|TWST: Gross Profit Ratio|TXG (10xgenomics.com) - Gross Margin|NTLA (Intellia Therapeutics, Inc.) - Gross Profit Ratio|Gross Profitability Stoke Corp (STOK)|Return on Sales by Gross Profit BioLife|Gross Margin WVE (Wave Life Sciences Ltd)|MAZE: Gross Return on Sales|Sionna Therapeutics, Inc. - Gross Margin|Gross Profit Rate PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Return on Gross Profit|QURE - Return on Sales by Gross Profit|RGNX (REGENXBIO Inc) - Gross Margin|solidbio.com (SLDB) - Return on Sales by Gross Profit|Gross Profitability Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Gross Return on Sales|Benitec Biopharma - Return on Gross Profit|DSGN: Gross Return on Sales|RCKT: Return on Gross Profit|FDMT - Gross Margin|LXEO: Gross Margin|Korro Bio Inc. - Gross Profit Rate|EDIT (editasmedicine.com) - Gross Margin|Gross Profitability SLN|Gross Profitability ProQR Therapeutics NV (PRQR)|Codexis - Gross Return on Sales|Gross Profitability Sangamo SGMO|NAUT: Gross Return on Sales|MGX: Return on Gross Profit|Gross Profit Margin Precision BioSciences|GBIO (generationbio.com) - Return on Gross Profit|Gross Profit Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Gross Margin|Gross Return on Sales IMNN (Imunon, Inc.)|Gross Margin PHIO|MBIO - Gross Profit Margin|Gross Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Gross Profit Margin|Applied DNA - Gross Margin|Gross Profit Margin Bluebird Bio|ImmunoPrecise (IPA) - Gross Profitability|Gross Profitability Margin OMGA (Omega)|Gross Profitability Singular Genomics Systems|Gross Profit Margin regulusrx.com RGLS|Gross Profitability Syros Pharmaceuticals Inc. (SYRS)|Return on Sales by Gross Profit Codex DNA|Gross Profitability TRACON TCON|Unity Biotechnology, Inc - Gross Profitability